The Administrative Core is designed to provide overall leadership for the program project. The P.I., with the support of an administrative secretary, organizes and manages the different components of the program. This includes frequent interactions with the Co-P.l., Lead Investigators, and Core Leaders, internal program review and planning, organization of work-in-progress meetings, external review, scientific seminar series, and overall representation of the needs of the scientific and administrative programs. Core A communicates with the external and internal advisors, the Cancer Center Directors of the Wistar Institute, University of Pennsylvania, Memorial Sloan Kettering Cancer Center, and the NCI program staff. This Core serves the needs of the entire program on the etiology, progression and therapy of melanoma for the institutions on the Wistar/Penn and MSKCC campuses.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
2P01CA025874-30A1
Application #
8129147
Study Section
Special Emphasis Panel (ZCA1-RPRB-O (J1))
Project Start
2011-04-01
Project End
2016-03-31
Budget Start
2011-08-25
Budget End
2012-03-31
Support Year
30
Fiscal Year
2011
Total Cost
$143,886
Indirect Cost
Name
Wistar Institute
Department
Type
DUNS #
075524595
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Vitiello, Marianna; Tuccoli, Andrea; D'Aurizio, Romina et al. (2017) Context-dependent miR-204 and miR-211 affect the biological properties of amelanotic and melanotic melanoma cells. Oncotarget 8:25395-25417
Krepler, Clemens; Sproesser, Katrin; Brafford, Patricia et al. (2017) A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. Cell Rep 21:1953-1967
Somasundaram, Rajasekharan; Zhang, Gao; Fukunaga-Kalabis, Mizuho et al. (2017) Tumor-associated B-cells induce tumor heterogeneity and therapy resistance. Nat Commun 8:607
Leu, Julia I-Ju; Barnoud, Thibaut; Zhang, Gao et al. (2017) Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function. Oncotarget 8:45656-45669
Taylor, Laura A; Abraham, Ronnie M; Tahirovic, Emin et al. (2017) High ALDH1 expression correlates with better prognosis in tumorigenic malignant melanoma. Mod Pathol 30:634-639
Shannan, Batool; Chen, Quan; Watters, Andrea et al. (2016) Enhancing the evaluation of PI3K inhibitors through 3D melanoma models. Pigment Cell Melanoma Res 29:317-28
Yeh, Iwei; Tee, Meng Kian; Botton, Thomas et al. (2016) NTRK3 kinase fusions in Spitz tumours. J Pathol 240:282-290
Zhang, Gao; Frederick, Dennie T; Wu, Lawrence et al. (2016) Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors. J Clin Invest 126:1834-56
Talevich, Eric; Shain, A Hunter; Botton, Thomas et al. (2016) CNVkit: Genome-Wide Copy Number Detection and Visualization from Targeted DNA Sequencing. PLoS Comput Biol 12:e1004873
Shannan, Batool; Perego, Michela; Somasundaram, Rajasekharan et al. (2016) Heterogeneity in Melanoma. Cancer Treat Res 167:1-15

Showing the most recent 10 out of 374 publications